Use of virtual reality in oncology: From the state of the art to an integrative model - Université Paul Valéry Montpellier 3 Accéder directement au contenu
Article Dans Une Revue Frontiers in Virtual Reality Année : 2022

Use of virtual reality in oncology: From the state of the art to an integrative model

Hélène Buche
  • Fonction : Auteur
Aude Michel

Résumé

Over the past 20 years, virtual reality (VR) has been the subject of growing interest in oncology. More and more researchers are studying the effects of virtual environments to contribute to current thinking on technologies likely to support patients undergoing oncological treatment. Recent research highlights how VR can divert attention while reducing anxiety in stressful healthcare situations through its multisensory and participative nature. VR appears to be a promising tool capable of reducing cancer-related anxiety symptoms, improving treatment adherence, and increasing satisfaction with oncology care. While the literature reports these positive effects in the therapeutic management of cancer, few studies have focused on theoretical models capable of explaining the psychological benefits of virtual immersion. This literature review provides a theoretical framework combining results from all relevant empirical work in oncology. The review can help researchers identify the optimal conditions for using VR in oncology and bridge the gap between divergent devices, modalities, and practices (e.g., headmounted displays, environments, interactivity, immersion time).

Dates et versions

hal-03975127 , version 1 (06-02-2023)

Identifiants

Citer

Hélène Buche, Aude Michel, Nathalie Blanc. Use of virtual reality in oncology: From the state of the art to an integrative model. Frontiers in Virtual Reality, 2022, 3, ⟨10.3389/frvir.2022.894162⟩. ⟨hal-03975127⟩

Collections

UNIV-MONTP3
13 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More